Blockade of the CD93 pathway normalizes tumor vasculature to facilitate drug delivery and immunotherapy

  • Yi Sun
    Department of Surgery, University of Colorado Anschutz Medical Campus, Aurora, CO 80045, USA.
  • Wei Chen
    Department of Surgery, University of Colorado Anschutz Medical Campus, Aurora, CO 80045, USA.
  • Robert J. Torphy
    Department of Surgery, University of Colorado Anschutz Medical Campus, Aurora, CO 80045, USA.
  • Sheng Yao
    Department of Immunobiology, Yale University School of Medicine, New Haven, CT 06520, USA.
  • Gefeng Zhu
    Department of Immunobiology, Yale University School of Medicine, New Haven, CT 06520, USA.
  • Ronggui Lin
    Department of Surgery, University of Colorado Anschutz Medical Campus, Aurora, CO 80045, USA.
  • Roberta Lugano
    Department of Immunology, Genetics and Pathology, Science for Life Laboratory, Rudbeck Laboratory, Uppsala University, 75185 Uppsala, Sweden.
  • Emily N. Miller
    Department of Surgery, University of Colorado Anschutz Medical Campus, Aurora, CO 80045, USA.
  • Yuki Fujiwara
    Department of Surgery, University of Colorado Anschutz Medical Campus, Aurora, CO 80045, USA.
  • Li Bian
    Department of Pathology, University of Colorado Anschutz Medical Campus, Aurora, CO 80045, USA.
  • Linghua Zheng
    Department of Immunobiology, Yale University School of Medicine, New Haven, CT 06520, USA.
  • Sudarshan Anand
    Department of Cell, Development and Cancer Biology, Oregon Health and Science University, Portland, OR 97239, USA.
  • Fan Gao
    Caltech Bioinformatics Resource Center at Beckman Institute, California Institute of Technology, Pasadena, CA 91125, USA.
  • Weizhou Zhang
    Department of Pathology, University of Florida, Gainesville, FL 32610, USA.
  • Sarah E. Ferrara
    University of Colorado Comprehensive Cancer Center, Aurora, CO 80045, USA.
  • Andrew E. Goodspeed
    University of Colorado Comprehensive Cancer Center, Aurora, CO 80045, USA.
  • Anna Dimberg
    Department of Immunology, Genetics and Pathology, Science for Life Laboratory, Rudbeck Laboratory, Uppsala University, 75185 Uppsala, Sweden.
  • Xiao-Jing Wang
    Department of Pathology, University of Colorado Anschutz Medical Campus, Aurora, CO 80045, USA.
  • Barish H. Edil
    Department of Surgery, University of Oklahoma Health Sciences Center, Oklahoma City, OK 73104, USA.
  • Carlton C. Barnett
    Department of Surgery, University of Colorado Anschutz Medical Campus, Aurora, CO 80045, USA.
  • Richard D. Schulick
    Department of Surgery, University of Colorado Anschutz Medical Campus, Aurora, CO 80045, USA.
  • Lieping Chen
    Department of Immunobiology, Yale University School of Medicine, New Haven, CT 06520, USA.
  • Yuwen Zhu
    Department of Surgery, University of Colorado Anschutz Medical Campus, Aurora, CO 80045, USA.

書誌事項

公開日
2021-07-28
DOI
  • 10.1126/scitranslmed.abc8922
公開者
American Association for the Advancement of Science (AAAS)

この論文をさがす

説明

<jats:p>Disruption of the molecular interaction between CD93 and IGFBP7 improves tumor vascular functions and thereby facilitates therapeutic interventions.</jats:p>

収録刊行物

  • Science Translational Medicine

    Science Translational Medicine 13 (604), eabc8922-, 2021-07-28

    American Association for the Advancement of Science (AAAS)

被引用文献 (1)*注記

もっと見る

問題の指摘

ページトップへ